IL10 and Sepsis: Early recognition of late-sepsis biomarkers, such as decreased lymphocyte count, increased MDSC production, increased IL-10 levels, changes in GPR18 expression, and decreased HLA-DR expression, will help with targeted diagnoses and treatments.